$TDY

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.

Original reporting
Published Aug 14, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)? — source image
Decision brief

The 30-second read

$TDYNeutralMed
01

Why it matters

For TDY, the key trading question is whether the company can credibly deliver returns on a roughly $1.1B transaction when synergies are not quantified. For VREX, the key trading question is deal certainty and spread compression toward the $18.90 offer price.

02

Market read

This is a fresh M&A catalyst with explicit offer terms and a stated premium, creating immediate spread-trading opportunities and near-term volatility around deal certainty.

03

What to watch

Financing structure, regulatory/antitrust review timeline, and integration milestones are not discussed here, yet they can dominate spread behavior between announcement and closing.

Relevance 9/10Novelty 7/10Timing: after-hours/next-session positioning following the announced acquisition agreement

Background

The article frames Teledyne’s acquisition of Varex as a portfolio-complement deal in X-ray imaging components, highlighting premium paid and the lack of quantified synergy/return targets.

Company-level read

Ticker impact

$TDYNeutralMedium confidence
Context

Teledyne agreed to acquire Varex for $18.90 per share in cash, valuing the deal at about $1.1B including equity awards and net debt.

Expected impact

Near-term TDY reaction likely depends on perceived synergy credibility and financing/closing risk; absent new quantified targets, volatility can persist.

Evidence & confidence

The article highlights the 52% premium, but also notes TDY shares slipped only 0.15%, implying limited immediate threat to shareholder value. It also stresses synergies are cited but not quantified, which can cap enthusiasm until more details emerge.

$VREXBullishHigh confidence
Context

Varex surged 48.5% to $18.42 after Teledyne’s acquisition agreement, with the offer representing a 52% premium to Varex’s unaffected close.

Expected impact

VREX may track the deal spread; further upside is likely limited unless deal terms improve or closing risk declines.

Evidence & confidence

The article provides the offer price ($18.90), the premium (52%), and notes Varex closed about 2.5% below the offer, implying roughly 2.6% upside to the deal price. That directly frames near-term trading around spread and deal risk.

Market effects

Could increase competitive pressure and consolidation expectations in X-ray imaging components (detectors, tubes, photon-counting) as buyers seek broader imaging portfolios.

Primarily US-listed names; limited direct regional read-through beyond US industrial/healthcare imaging supply chains.

Imaging components serve medical and security/industrial inspection globally, so integration success could affect supplier dynamics worldwide.

Counterpoint

The premium may be justified by strategic fit, but without quantified synergy, the market may be underpricing execution risk or overpaying for overlapping product lines.

Key entities

  • Teledyne Technologies

    Agreed to acquire Varex for $18.90 per share in cash, valuing the transaction at about $1.1B including equity awards and net debt.

  • Varex Imaging

    Received a cash offer at a 52% premium; stock jumped sharply on the announcement and closed below the offer price.

Related articles

$TDYHighAI 10/10

Teledyne to Acquire Varex Imaging Corporation

Teledyne Technologies agreed to acquire Varex Imaging in a cash deal for $18.90 per Varex share, valuing the transaction at about $1.1 billion including equity awards and net debt as of April 3, 2026. Boards approved unanimously. Closing is expected in early 2027, pending regulatory and Varex stockholder approvals.

$TDYMed

Fitch upgrades Teledyne Technologies rating on strong cash flow

Fitch Ratings upgraded Teledyne Technologies Inc. (NYSE:TDY) long-term issuer default rating to BBB+ from BBB and raised its senior unsecured revolver and notes to BBB+ from BBB, with a Stable outlook. Fitch cited stronger free cash flow, low 2.0x EBITDA leverage, debt near $2.0B, and funded backlog about $5.0B. Fitch also referenced TDY’s $1.1B acquisition of Varex Imaging.

$VREXHighAI 10/10

Five Months After a $490 Million Refinancing, Utah’s Varex Imaging Agrees to be Acquired by Teledyne in a $1.1 Billion Deal

Varex Imaging (NASDAQ:VREX) agreed to be acquired by Teledyne Technologies (NYSE:TDY) for $18.90 per share in a cash deal valued at about $1.1 billion, including Varex equity awards and net debt. Boards approved; close expected early 2027 after shareholder and regulatory approvals. Varex completed a $490 million refinancing in March 2026.

$VREXMed

Varex Imaging Corporation revenues hit USD 211M in Q3FY26

Varex Imaging reported unaudited Q3 FY2026 results: revenue of $211 million, GAAP gross margin 36% (non-GAAP 37%), GAAP operating margin 11% (non-GAAP 12%), and GAAP diluted EPS $0.37 (non-GAAP $0.31). Third-quarter revenues rose 4% YoY, with Medical $134 million and Industrial $77 million. The company received $17 million in U.S. Customs refunds tied to IEEPA tariffs.

$VREXMed

Varex Q3 FY2026 Results Show Revenue Growth and Margin Expansion Ahead of Teledyne Transaction

Varex Imaging (NASDAQ:VREX) reported Q3 FY2026 revenue of $211 million, up 4% year over year, with Industrial revenue at $77 million and Medical at $134 million. Non-GAAP gross margin rose to 37% from 34% and non-GAAP EPS increased to $0.31 from $0.13. Tariff refunds and customer reimbursements added about $10 million to gross profit. Varex cancelled its earnings call and declined guidance due to a pending Teledyne Technologies transaction.